Insider Selling: 23andMe Holding Co. (NASDAQ:ME) Insider Sells $18,889.99 in Stock

23andMe Holding Co. (NASDAQ:ME) insider Kathy L. Hibbs sold 38,551 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $0.49, for a total value of $18,889.99. Following the completion of the sale, the insider now owns 1,252,315 shares in the company, valued at $613,634.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

23andMe Trading Down 3.0 %

NASDAQ ME opened at $0.48 on Thursday. 23andMe Holding Co. has a 12 month low of $0.35 and a 12 month high of $2.21. The firm has a market capitalization of $233.11 million, a P/E ratio of -0.43 and a beta of 1.24. The business has a fifty day simple moving average of $0.49 and a 200 day simple moving average of $0.69.

23andMe (NASDAQ:ME) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share for the quarter. 23andMe had a negative net margin of 210.48% and a negative return on equity of 52.99%. The firm had revenue of $44.75 million for the quarter, compared to the consensus estimate of $56.30 million.

Analyst Ratings Changes

Separately, Citigroup reduced their target price on 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a report on Tuesday, April 16th.

Institutional Investors Weigh In On 23andMe

A number of institutional investors have recently added to or reduced their stakes in the company. Swiss National Bank grew its position in 23andMe by 2.5% in the 3rd quarter. Swiss National Bank now owns 579,800 shares of the company’s stock worth $567,000 after purchasing an additional 14,000 shares in the last quarter. Commonwealth Equity Services LLC boosted its stake in 23andMe by 4.6% in the third quarter. Commonwealth Equity Services LLC now owns 370,934 shares of the company’s stock valued at $363,000 after acquiring an additional 16,390 shares during the last quarter. Raymond James & Associates boosted its stake in 23andMe by 113.5% in the third quarter. Raymond James & Associates now owns 36,173 shares of the company’s stock valued at $35,000 after acquiring an additional 19,233 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in 23andMe by 58.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 61,167 shares of the company’s stock valued at $56,000 after acquiring an additional 22,460 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in 23andMe by 68.3% in the first quarter. China Universal Asset Management Co. Ltd. now owns 60,653 shares of the company’s stock valued at $32,000 after acquiring an additional 24,604 shares during the last quarter. 36.10% of the stock is owned by institutional investors.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.